Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers-Reference-Cited by-同舟云学术

Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers

Published:2019-07-15 Issue:1 Volume:19 Page:
ISSN:1470-7330
Container-title:Cancer Imaging
language:en
Short-container-title:Cancer Imaging

Author:

Zhao Li,Ma Xiaohong,Liang Meng,Li Dengfeng,Ma Peiqing,Wang Sicong,Wu Zhiyuan,Zhao Xinming^ORCID

Funder

CAMS Innovation Fund for Medical Sciences

PUMC Youth Fund

Beijing Hope Run Special Fund of Cancer Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Radiological and Ultrasound Technology

Link

http://link.springer.com/content/pdf/10.1186/s40644-019-0234-4.pdf

Reference35 articles.

1. Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168–79.

2. Bergquist A, von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol. 2015;29(2):221–32.

3. Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009;29(3):683–700.

4. Amini N, Ejaz A, Spolverato G, Kim Y, Herman JM, Pawlik TM. Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis. J Surg Oncol. 2014;110(2):163–70.

5. Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol. 2016;23(1):235–43.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring a multiparameter MRI–based radiomics approach to predict tumor proliferation status of serous ovarian carcinoma;Insights into Imaging;2024-03-18

2. Radiomics and liver: Where we are and where we are headed?;European Journal of Radiology;2024-02

3. Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging;Critical Reviews in Oncology/Hematology;2024-02

4. Identifying patients suitable for targeted adjuvant therapy: advances in the field of developing biomarkers for tumor recurrence following irradiation;Expert Review of Precision Medicine and Drug Development;2023-11-16

5. Postoperative Prognosis of Non-alcoholic Fatty Liver Disease-Associated Intrahepatic Cholangiocarcinoma: a Multi-center Propensity Score Matching Analysis;Journal of Gastrointestinal Surgery;2023-11